Uptake of taurocholate and the intrinsic factor-cobalamin complex occurs predominantly in ileal villous cells by Essandoh, Louis K.
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1981
Uptake of taurocholate and the intrinsic factor-
cobalamin complex occurs predominantly in ileal
villous cells
Louis K. Essandoh
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Essandoh, Louis K., "Uptake of taurocholate and the intrinsic factor-cobalamin complex occurs predominantly in ileal villous cells"
(1981). Yale Medicine Thesis Digital Library. 2565.
http://elischolar.library.yale.edu/ymtdl/2565

MEDICAL LIBRARY 
Digitized by the Internet Archive 
in 2017 with funding from 
The National Endowment for the Humanities and the Arcadia Fund 
https://archive.org/details/uptakeoftaurochoOOessa 



UPTAKE OF TAUROCHOLATE AND THE INTRINSIC FACTOR-COBALAMIN COMPLEX 
OCCURS PREDOMINANTLY IN ILEAL VILLOUS CELLS 
by 
LOUIS K. ESSANDOH 
Chemical Engineer 
Massachusetts Institute of Technology (1977) 
Master of Science 
Massachusetts Institute of Technology (1977) 
Bachelor of Science in Chemical Engineering 
Massachusetts Institute of Technology (1977) 
Bachelor of Science in Chemistry 
Massachusetts Institute of Technology (1977) 
A thesis submitted to the Yale University School of Medicine 
in Partial Fulfillment of the Requirements for the degree of 
DOCTOR OF MEDICINE 
March 1981 
Supervised by: 
Cyrus R. Kapadia, M.D. 
Assistant Professor of Medicine 
■ill 3 
Y t O' 
DEDICATION 
TO MY DEAR PARENTS 
HE FOR HIS INSISTENCE THAT I STUDY MEDICINE 
SHE FOR NOT DISSENTING 

-3- 
ACKNOWLEDGMENT 
Writing the acknowledgments section of this thesis was, without 
question, the most pleasurable aspect of the work since it afforded me 
the opportunity to put in print the gratitude that I was unable to express 
adequately by other means to the many individuals who made this work 
possible. 
It will be well nigh impossible to adequately thank my thesis 
suppervisor and mentor, Cyrus R. Kapadia, M.D., Assistant Professor of 
Medicine, and I shall not attempt to do so. Suffice it to say that he 
played a paramount role in every single aspect of this work. 
The name of Robert M. Donaldson, M.D., Professor of Medicine, 
Yale University School of Medicine and Chief of Medical Services, West 
Haven Veterans Administration Hospital, more aptly belongs on the title 
page as a co-supervisor of this work. In the unusual modesty so charac¬ 
teristic of him, Dr. Donaldson edited his name out from the final draft. 
I couldn’t disagree with him more. Fortunately, this section was written 
late enough to escape his editorial axe, and I have seized the opportunity 
to express to him my sincerest appreciation for suggesting the project, 
providing the laboratory facilities and for making available to me his 
immense experience in this field. I am especially grateful for allowing 
me to quote from his yet-to-be published review article on cobalamin 
transport. 

-4- 
Miss Kathy McManus was of invaluable help in initiating me to the 
laboratory and assisting in all aspects of the experimental work. Miss 
Nana Frema Busia helped with proofreading and typing of the rough draft. 
The final draft was typed by Mrs. Annie Cooper-Brown. I am extremely 
grateful to this wonderful trio. 
Finally, I wish to acknowledge the continued support and encourage¬ 
ment of my dear parents, to whom this thesis is dedicated. Needless to 
say, the decision they took more than twenty six years ago culminated in 
this thesis. 

-5- 
TABLE OF CONTENTS 
Page 
Dedication . 2 
Acknowledgments  3 
Table of Contents . . 5 
List of Tables. 7 
List of Figures.  8 
List of Abbreviations Used. 8 
Abstract  9 
CHAPTER 1 BACKGROUND INFORMATION: OBJECTIVES 
1.1 Intestinal Epithelial Cell Renewal and Differentiation .... 11 
1.2 Objectives of the Present Work. 12 
1.3 Methods for the Preparation of Isolated Crypt and Villous Cells. 13 
1.4 Biochemical Changes Accompanying Crypt to Villous Maturation . 14 
1.5 Review of Cobalamin Transport . 16 
1.6 Review of Bile Acid Transport.22 
CHAPTER 2 MATERIALS AND METHODS 
2.1 Solutions and Reagents.  26 
2.2 Animals. 27 
2.3 Preparation of Villous and Crypt Cell Suspensions . 27 
2.4 Enzyme Assays. 28 
2.5 Cell Viability Studies.31 
2.6 IF-Cbl Binding Studies. 31 
2.7 Bile Acid Binding Studies. 32 

-6- 
TAELE OF CONTENTS (continued) 
Page 
CHAPTER 3 RESULTS AND DISCUSSION 
3.1 Enzyme Assays.36 
3.2 Cell Viability Studies.AO 
3.3 IF-Cbl Binding Studies . ... 40 
3.4 Bile Acid Uptake Studies. 46 
3.5 Conclusion.50 
BIBLIOGRAPHY  53 

-7- 
LIST OF TABLES 
Page 
1. Table 1.1: Biochemical changes accompanying crypt cell 
to villous cell aturation. 15 
2. Table 2.1: Experimental protocol for the binding of free 
“^CoCbl or IF-^CoCbl to "villous" and crypt" cells . 33 
3 
3. Table 2.3: Experimental protocol for the uptake of H-Tauro- 
cholate by guinea pig ileal cells . 35 
4. Table 3.1: Results of enzyme assays on the first 15 minute 
("villous") fraction of guinea pig ileal cells . 37 
5. Table 3.2: Results of enzyme assays on the last 20 minute 
("crypt") fraction of guinea pig ileal cells . 38 
6. Table 3.3: Crypt/villous ratio of enzymatic activity . 41 
7. Table 3.4: Results of the uptake of Free and IF-bound ^CoCbl 
by ileal villous cells . 44 
8. Table 3.5: Results of the uptake of Free and IF-bound ^CoCbl 
by ileal crypt cells 45 
9. Table 3.6: Comparison of the uptake of free and IF-bound "^CoCbl 
by jejunal and ileal crypt cells . 45 
3 
10. Table 3.7: Results of the uptake of H-Taurocholate by jejunal 
and ileal villous cells  49 
3 
11. Table 3.8: Results of the uptake of H-Taurocholate by jejunal 
and ileal crypt cells  49 

-8- 
LIST OF FIGURES 
Page 
1. Figure 1.1 Cobalamin molecule... 17 
2. Figure 2.1 Flow diagram for obtaining villous and crypt 
cell preparations. 29 
3. Figure 3.1 Distribution of enzymes in the two cell fractions 
of guinea pig ileun  
14 
4. Figure 3.2a Incorporation of C-labeled leucine into protein 
by ileal villous cells . 
14 
5. Figure 3.2b Incorporation of C-labeled leunine into protein 
by ileal crypt cells  
6. Figure 3.3 Uptake of Free and IF-bound “^CoCbl by guinea pig 
jejunal and ileal crypt and villous cells . 
3 
7. Figure 3.4 Uptake of H-Taurocholate by jejunal and ileal 
crypt and villous cells . 
39 
42 
43 
47 
48 
LIST OF ABBREVIATIONS USED 
IF 
Cbl 
TC 
EDTA 
KRB 
Intrinsic Factor 
Cobalamin 
Taurocholate 
Ethylene Diamine Trichloroactetate 
Krebs-Ringers-Bicarbonate buffer solution 

-9- 
UPTAKE OF TAUROCHOLATE AND THE INTRINSIC FACTOR-COBALAMIN COMPLEX 
OCCURS PREDOMINANTLY IN ILEAL VILLOUS CELLS 
by 
Louis K. Essandoh 
ABSTRACT 
Both the intrinsic factor (IF) mediated uptake of cobalamin (Cbl) 
and the active transport of conjugated bile salts occur predominantly in 
the distal ileum; however, it is unclear which cell type (villous, crypt, 
or both) possesses the apparatus specific for these transport processes. 
To resolve this, we measured the uptake of free and IF-bound Co-labeled 
57 3 3 
cyanocobalamin ( CoCbl) and of H-labeled taurocholate ( H-TC) by isolated 
guinea pig crypt and villous cells prepared by a modification of the method 
of Weiser. Cell preparations were checked for purity by measuring levels 
of thymidine kinase (as a crypt cell marker) and of sucrase and alkaline 
phosphatase (as villous cell markers). Cell viability was established by 
the steady rate of incorporation of tritium-labeled leucine into protein 
by both villous and crypt cell preparations. Incubation of ileal villous 
cells with IF-bound "^CoCbl at 37°C for 30 minutes resulted in a level of 
uptake 40 times greater than incubation with free Cbl under the same con¬ 
ditions. However, IF-mediated uptake was absent with either ileal crypt 
cells or with jejunal crypt or villous cells. Similar results were obtained 
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when crypt and villous cell preparations were incubated with H-TC for 
5 minutes. Here, ileal villous cell uptake was 41-fold, 35-fold, and 
39-fold more than the levels for ileal crypt, jejunal villous, and jejunal 
crypt cell preparations respectively. These results suggest that the 
differentiated ileal villous cell, but not the undifferentiated ileal crypt 
cell, possesses the apparatus for the uptake of conjugated bile salts and 
the intrinsic factor-cobalamin complex. Jejunal enterocytes, differentiated 
or undifferentiated, lack this capacity. 
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CHAPTER 1 
BACKGROUND INFORMATION; OBJECTIVES 
1.1 Intestinal Epithelial Cell Renewal and Differentiation 
In order to augment its absorptive surface area, the small intes¬ 
tinal mucosa is organized into 0.5 - 1.5 mm-long finger-like projections 
called villi. Opening into the bases of these villi are 400 ym-long simple 
tubular glands which form the crypts of Lieberkuhn. The (simple columnar) 
epithelium that lines the villi continues into the upper haves of the walls 
of the crypts as well, but the lower halves of the crypt cells are lined by 
highly undifferentiated cells which show vigorous mitotic activity. This 
anatomical fact (of the localization of proliferative cells to the crypts) 
is a long established one (1,2). Equally well established is the existence 
of a gradient of defferentiation from crypt cells up the villus surface (3). 
This gradient is both a morphological as well as a functional one since 
during its migration the crypt cell acquires many of the specialized enzymes 
required for digestion (4,5) whilst losing its DNA (6)-, RNA (7)-, and 
cholesterol (8)- synthesizing enzymes. Autoradiographic methods involving 
the in vivo injection of radioactively-labelled thymidine have been used to 
confirm that in laboratory animals it takes the newly-formed crypt cell 
24-76 hours to reach full maturity at the villus tip, where it desquamates 
into the intestinal lumen. Lipkin and Bell (9) have reviewed this renewal 
process extensively. 
Inspite of the above knowledge, the actual factors that determine 
whether a given crypt cell remains in its undifferentiated form in the crypt 
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and proliferates or migrates upward and differentiates are not known. 
Carnie et al (10,11) have advanced the theory that all crypt cells migrate 
up the villus and are either proliferative (P) cells, which are capable of 
dividing but incapable of differentiating, or non-proliferative (Q) cells 
which can differentiate but cannot divide. Division of a P cell may pro¬ 
duce two P cells or two Q cells; however, for reasons as yet unclear but 
probably related to local environmental influences (9), the division of a 
P cell deep in the crypts produces only P cells. During migration up the 
crypt, an increasing fraction of P-cell dividions yields Q cells until, at 
the uppermost level of the crypt, Q cells are formed exclusively from P-cell 
divisions. At this level, proliferation ceases and differentiation is 
accelerated. 
1.2 Objectives of the Present Work 
While the phenomenon of crypt cell differentiation is of general 
interest in cellular biology, it takes on added relevance in the field of 
gastrointestinal physiology because of its potential implications in the 
understanding of human health and disease states. It has been a long-held 
belief of many gastrointestinal physiologists that in general the absorptive 
functions of the intestine are performed exclusively by the mature villous 
cell whereas the secretory functions are the mainstay of the crypt cells. 
Two of the better-studied absorptive functions of the intestine are the 
intrinsic factor (IF) mediated uptake of cobalamin (Cbl) and the active 
transport of conjugated bile salts. Both of these transport processes have 
been shown to reside predominantly in the ileum but it is unclear whether it 
is the differentiated villous cell or the undifferentiated crypt cell that 

-13- 
has the capacity for such transport. We were therefore interested in 
measuring the uptake of free and IF-bound “^Co-labeled cyanocobalamin 
57 3 3 ( CoCbl) and of H-labeled taurocholate ( H-TC) by isolated guinea pig 
crypt and villous cells. To do this, we utilized a modification of the 
method of Weiser (23) to obtain pure preparations of crypt and villous cells. 
Purity of cell preparations was confirmed by assays of enzymes specific for 
one or the other cell type. Cell viability was established by the steady 
rate of incorporation of tritium-labeled leucine into protein by both villous 
and crypt cell preparations. Finally, the uptake studies were repeated with 
jejunal enterocytes to confirm the absence of uptake of IF-Cbl or TC in 
these cells. 
1.3 Methods for the Preparation of Isolated Crypt and Villous Cells 
Various and sundry methods for the preparation of isolated crypt 
and villous cells have been devised. These may be broadly categorized into 
mechanical and biochemical methods. The mechanical methods include that 
of Dietschy and Siperstein (8) in which isolated crypt and villous cells 
were obtained simply by scraping the intestinal mucosa with a glass plate, 
first lightly (to produce the more superficial villous cells), then more 
forcefully (to yield the crypt cells). More refined versions of the scraping 
method have been used by Imondi et al (12) in their "intestinal planning 
apparatus" which was capable of successive 125]i cuttings because of an 
incorporated micrometer, and by Das and Gray (13) using a cryostat and a 
dissecting microscope. Harrison and Webster (14) and Sjostrand (15) obtained 
pure preparations of crypt and villous cells by mechanical vibration of 
everted intestine in appropriate buffer solutions. 
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The biochemical methods include enzymatic digestion with trypsin 
(16, 17), trypsin-pancreatin (18), or lysozyme (19). A difficulty inherent 
in these protease digestion methods is that long incubation times (or high 
enzyme concentrations) result in cells of low viability whereas short incu¬ 
bation times (or low enzyme concentrations) give poor yield; since the 
optimum enzyme concentration and incubation time are highly variable, any 
studies that utilize cells thus prepared are bound to yield inconsistent 
results. To circumvent this difficulty, recent techniques of intestinal 
mucosal cell fractionation utilize incubation in calcium-binding agents 
such as citrate (20, 21) or EDTA (22, 23). We used Merchant and Heller's 
(24) modification of the EDTA-incubation method of Weiser (23) to dissociate 
guinea-pig intestinal cells into pure crypt and villous cell preparations 
for use in the binding studies to be described in Chapter 2. 
1.4 Biochemical Changes Accompanying Crypt to Villous Maturation 
As has already been mentioned, an inevitable concomitant of crypt 
cell differentiation is the loss of certain biochemical markers and the 
acquisition of others. The enzymes of the intestinal epithelium may be 
classified into three groups on the basis of the ratios of their activities 
in crypt cells and in villous cells (25). In the first group (see Table 1.1), 
the ratio of the enzymatic activity in crypt cells to that in villous cells 
is substantially greater than unity. This group comprizes the enzymes 
associated with pyrimidine and pyrimidine nucleotide biosynthesis. By con¬ 
trast, in group 3 the ratios of enzyme activities in crypt cells to villous 
cells if much less than one. The brush border enzymes — the disaccharidases, 
oligopeptidases, and alkaline phosphatase — belong to this group. Finally, 
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TABLE 1.1 
Ratio 
crypt 
of enzymatic activity in 
cells: villous cells Reference 
Group 1 
Thymidine Kinase 50 26 
Aspartate carbamoyltransferase 2.3 27 
Uridine Kinase 1.7 28 
Group 2 
Acid B-galactosidase 0.86 29 
B-glucuronidase 0.88 30 
Acid phosphatase 0.83 31 
Group 3 
Maltase 0.17 32 
Lactase 0.25 29 
Invertase (sucrase) 0.11 29 
Dipeptidase 0.43 33 
Alkaline phosphatase 0.49 34 
Table showing the changes in enzymes levels accompanying crypt 
cell to villous cell maturation. 
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enzymes constituting group 2 have similar activities in crypt and villous 
cells, that is, the ratio of their activities in these two cell types 
approaches unity. 
It follows from Table 1.1 that Group 1 enzymes may be used as 
markers for the crypt cell and Group 3 enzymes as markers for the villous 
cell preparation. This fact provides a method for checking the consistency 
of cell separations. We chose to assay thymidine kinase (as a crypt cell 
marker), sucrase, alkaline phosphatase (as villous cell markers), and acid 
phosphatase. The acid phosphatase assay was done as a further check on the 
purity of cell preparations since previous work has shown that the ratio of 
enzymatic activity is close to 0.85. 
1.5 Review of Cobalamin Transport 
The term 'cobalamin' refers to a family of natural and semi-synthetic 
compounds all of which consist of two major portions — a planar group 
(the corrin nucleus) and a "nucleotide" moiety lying perpendicular to it 
(fig. 1.1). 
In vivo, the cobalamins exist predominantly as hydroxycobalamin, 
methylcobalamin, and adenosylcobalamin. This fact notwithstanding, the 
term cyanocobalamin pervades the literature largely because of its historical 
position as the first of the cobalamins to be isolated. It is now known 
that the cyanide moiety is an artifact resulting from the use of charcoal in 
the original isolation procedures. In this work, the term "cobalamin" is 
used to mean "cyanocobalamin", the substance most often used in research on 
cobalamin transport. 
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FIGURE 1.1 
VITAMiN Bi;! CONGENERS 
Permissive Name R Group 
Cyanocobalamin 
(Vitamin B12) 
Hydroxocobclamin 
Meth/lcobalarmn 
5'-Deoxyodenos'/l- 
cobalamin 
N 
—CH 
-ch3 
—£'-Deo>./cder as,' 
Figure 1.1: The structural formula of the cobalamin molecule. 
The three major portions of the molecule are: 
1. A planar group or corrin nucleus - a porphyrin-like ring 
structure with four reduced pyrrole rings (designated A 
to D) linked to a central cobalt atom and extensively sub¬ 
stituted with methyl, acetamide, and propionamide residues. 
2. A 5,6-dimethylbenzimidazolyl nucleotide, which links almost 
at right angles to the corrin nucleus with bonds to the 
cobalt atom and to the propionate side chain of the D ring. 
3. A variable R group - the most important of which is found 
in the stable compounds cyanocobalamin and hydroxocobalamin 
and the active coenzymes methylcobalamin and 5-deoxyadeno- 
sylcobalamin. While there are a number of other cobalamin 
derivatives in nature, formed by covalent binding of various 
ligands to the cobalt atom, these are of no apparent value 
to man. 
(Reproduced from Goodman and Gilman (95)). 
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The cobalamin molecule is a relatively large molecule (molecular 
weight of 1300-1400 daltons) which possesses an appreciable water solubility 
because of the polar side groups on the corrin ring (fig. 1.1). The above 
properties of cobalamin preclude its efficient absorption by any simple, 
passive, transepithelial process. For one thing, the epithelial barriers 
that have to be traversed have an "effective pore size" many orders of 
magnitude smaller than the smallest diameter of the cobalamin molecule. 
Secondly, the relative hydrophobicity of the cobalamin molecule makes it 
incompatible with the lipid bilayer of the cell membrane. Little wonder, 
then, that a complex and highly specific transport process involving three 
different binding proteins has evolved for the assimilation and transport 
of this vitamin. The know cobalamin-binding proteins are intrinsic factor, 
transcobalamin II, and the R proteins. Whilst a knowledge of the role of 
intrinsic factor only is pertinent for the understanding of this work, the 
functions of the R proteins and transcobalamin II will be reviewed briefly 
for the sake of completeness. 
The R Proteins: 
This family of glycoproteins, so named because of their rapid 
electrophoretic migration (41), are found in granulocytes (as transcobalamin 
III), plasma (as transcobalamin I) and in many glandular secretions (saliva, 
gastric juice, bile, milk, tears) (42). In man they have a molecular weight 
of 56,000 to 66,000 daltons and a carbohydrate content of 33-40% (43). It 
appears that the R proteins function mainly as storage proteins for cobalamin. 
Indeed, most of the circulating endogenous cobalamin is bound to trans¬ 
cobalamin I. Thus it is conceivable that transcobalamin I binds cobalamin 
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for a slow, sustained delivery to tissues which then either use the cobalamin 
or excrete it. Consistent with this role for TC I is its very slow turnover 
rate (of several days). TC III on the other hand has an extremely rapid 
turnover rate (half life in plasma of the order of several minutes) and its 
role, if any, in the storage of cobalamin is less clear. As suggested by 
Carmel and Herbert (47) and by Scott et al (48), plasma TC III maybe an 
artifact resulting from its inevitable release from granulocytes after blood 
has been drawn. 
Transcobalamin II: 
Unlike intrinsic factor and the R proteins (which are glycoproteins), 
transcobalamin II is a polypeptide. It is found in plasma as a globulin of 
molecular weight 38,000 daltons (43). Most TC II is probably synthesized 
by the liver but minor amounts may be synthesized by the kidney and the 
intestine as well (44, 45). TC II synthesis by mouse monocytes has also been 
reported (46). Compared to TC I, circulating TC II has a fairly rapid turn¬ 
over rate (half-life of one to a few hours) and is found at a much lower 
concentration in plasma than TC I. 
Intrinsic Factor 
Intrinsic factor is a globular glycoprotein of molecular weight 
45,000 and a carbohydrate content of about 15%. In most animal species, 
including man, it is synthesized predominantly by the parietal (oxyntic) 
cells of the gastric mucosa and secreted as part of gastric juice (49, 50). 
In a few species, localization of intrinsic factor to the chief cell (rat, 
mouse) or the mucus cell (hog) has been demonstrated (49). Regardless of 
the site of synthesis, intrinsic factor secretion is stimulated by H?-receptor 
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agonists (51, 52, 53) and cholinergic agents (53) and inhibited by 
receptor antagonists (54). 
It has been inferred from the maximum amount of Cbl that can be 
bound to IF that each molecule of IF binds only one molecule of Cbl (35). 
The affinity of Cbl for the IF binding site is so great that binding occurs 
instantaneously (41, 36). Once bound, the IF-Cbl complex becomes signifi¬ 
cantly more resistant to proteolytic destruction than IF (37). 
Sequence of Events in Cobalamin Uptake 
Uptake of Cbl may occur by two distinctly different processes de¬ 
pending on the quantity of Cbl ingested. When physiologic amounts of Cbl 
are ingested, uptake occurs primarily by the IF-mediated process to be 
described below. With larger quantities of Cbl, as may exist in an in vitro 
incubation of Cbl with isolated cells, a non-specific, non-IF dependent 
diffusion mechanism may contribute to the measured uptake. For this reason, 
studies on IF-Cbl uptake must include control incubations with free Cbl; 
levels of uptake in the latter are subtracted from the IF-Cbl incubations 
to obtain the true amount of uptake ascribable to the IF-mediated mechanism. 
The orderly sequence of events involved in Cbl absorption was first 
proposed by Cooper and Castle (38) in 1960. Subsequent work by other investi¬ 
gators has established the correctness of most of the steps in the original 
proposal of Cooper and Castle. These events may be summarized as follows: 
1) dietary Cbl'is released from food protein complexes by acid gastric juice 
(38); 2) the released Cbl binds to salivary and gastric R proteins present 
in the stomach (39); 3) the Cbl-R protein complex reaches the proximal 
small intestine where pancreatic proteases rapidly degrade the R proteins with 
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the concomitant release of Cbl (39); 4) binding of Cbl with IF to form 
a macromolecular complex which, unlike the R proteins, is resistant to 
digestion by pancreatic proteases (37, 39); 5) the IF-Cbl complex binds 
to membrane receptors located in the distal ileal mucosa; there is evidence 
(40, 55, 56) that the site of the IF molecule which binds to the ileal 
receptor is different from that which bears the Cbl molecule; 6) the Cbl 
molecule is absorbed into the ileal mucosal cell and released into the 
portal circulation. 
Binding of the IF-Cbl complex to the ileal receptor (step 5, above) 
requires calcium ions and a pH greater than 5.6. It has been postulated 
| [ 
(57, 43) that Ca ions link certain critical anions on the IF molecule and 
the receptor to form "salt bridges" that maintain the IF molecule in an 
appropriate configuration for transfer of the Cbl molecule. 
While the seqence of Cbl uptake presented above is that currently 
held by most investigators to be correct, it must be mentioned that there 
is some evidence that an alternative mechanism of cobalamin absorption may 
exist. Steinberg et al (93) and Toskes et al (94) have presented evidence 
that in patients with pancreatic insufficiency, the failure to degrade R 
proteins (step 3) is unimportant in explaining the pathogenesis of Cbl 
malabsorption in these patients. 
Little is known about the transepithelial cell transport of Cbl once 
it is bound to the ileal mucosa. However, since this phase of the assimi¬ 
lation of Cbl is beyond the scope of this work, it will suffice to mention 
that there is some indirect evidence (58, 59, 60) that as Cbl leaves the 
ileal serosal surface, it is bound to an ileal pool of TC II which is distinct 
from circulating TC II. The newly absorbed Cbl enters the systemic circulation 
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where the Cbl is probably transferred to the systemic pool of TC II and 
thence to surface membrane receptors present on all cells. 
1.6 Review of Bile Acid Transport in the Small Intestine 
The earliest definitive work on the absorption of bile acids appears 
to have been that of Schiff (61) who demonstrated that these substances 
were readily absorbed by the small intestine but not by other regions of 
the gastrointestinal tract. Tappeiner (62), and later Frolicher (63) 
subsequently showed that bile acid absorption occured much more readily in 
the distal small intestine than the proximal small intestine. 
A large number of studies on the transepithelial absorption and 
secretion of bile acids have appeared in the literature over the past several 
decades (64, 65, 66, 67, 68). These studies have established with certainty 
that in most species, including man, bile acid absorption occurs predominantly 
in the distal ileum and to a lesser but measurable extent in the proximal 
small bowel. In a few species, including the hen (69, 70, 71, 72), however, 
bile acid uptake by the duodenum and jejunum has been shown to far exceed 
that in the ileum. This fact led to the suggestion that bile acid absorption 
may occur by two distinct mechanisms — a passive transport process and an 
active transport process — and that one or the other process may predomi¬ 
nate at different sites of the enterohepatic circulation depending on the 
species and certain other factors to be mentioned below. 
Lack and Weiner (73), using everted gut sac preparations of four 
equal segments obtained from the entire length of the small intestine, de¬ 
monstrated that bile acid uptake occurs by a passive process in the proximal 
half. Uptake in third-quarter intestinal segments was by both passive and 
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active transport processes, with a slight tendency toward the latter, 
whereas uptake in the distal quarter (ileum) was almost entirely due to 
active transport. These findings have been confirmed by other investi¬ 
gators (74, 75, 77). 
Passive Bile Acid Uptake 
Passive absorption of bile acids may be ionic or non-ionic depend¬ 
ing on the pK of the particular bile acid, which in turn depends on the 
nature of the moiety with which the bile acid is conjugated. In passive 
ionic diffusion, the absorbed bile acids are completely ionized. An ex¬ 
ample of this type of diffusion exists in taurine conjugated bile salts. 
These are completely ionized at every level of the small intestine because 
of their relatively low pK values (of the order of 2.0) compared to the pH 
3 
range of 6-8 that exists in the small intestine. For this reason, taurine 
conjugated bile acids may be absorbed by passive ionic diffusion. Glycine 
conjugates, on the other, have a pK of the order of 4.0 and in situations 
3 
where the small intestinal pH is abnormally low, significant amounts of the 
protonated (non-ionic) species may exist. In such a situation, glycine 
conjugated bile acids may be absorbed by both passive ionic and non-ionic 
diffusion. Similarly, since the pK of free bile acids is about 6.0, appre- 
ciable amounts of both protonated and unprotonated species exist for both 
passive ionic and passive non-ionic uptake to occur. 
It may be inferred, from the lipoid nature of epithelial membranes, 
that passive non-ionic diffusion is a much more rapid process than passive 
ionic diffusion. Dietschy et al (76) have shown this to be the case. The 
nature of the barriers that determine the rate of passive bile acid uptake 
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from the small intestine has been studied by Wilson and Dietschy (77). 
With highly ionized bile salts, the lipiod cell membrane was found to con¬ 
stitute the greatest resistance to penetration of the brush border. With 
unionized bile acids, the lipoid cell membrane was more penetrable but the 
fluid layer in immediate contact with the brush border offered a consider¬ 
able amount of resistance on account of the inherently poor mixing of the 
fluid lamella. 
It must be reiterated that in most species, including man, the 
quantitative contribution of passive bile acid absorption to the total bile 
acid pool in the enterohepatic circulation is minor. In certain pathological 
situations, however, passive bile acid uptake may be quantitatively signi¬ 
ficant or may even predominate. Thus, in syndromes in which there is gastric 
hypersecretion, the pH of the small intestine may be quite low and, as noted 
above, unionized glycine conjugates may be absorbed in significant amounts. 
Similarly, in the blind loop syndrome, bacterial overgrowth of the small 
bowel results in rapid deconjugation of bile acids. The pK of the latter 
3. 
is high enough for significant quantities of free bile acids to be absorbed. 
Active Transport of Bile Acids 
Active bile acid transport is an energy-dependent process and as 
such is inhibited by metabolic inhibitors (73, 74) and by oxygen depriva¬ 
tion (73). Active uptake of bile acids is also dependent on sodium. Thus, 
5. + + 
the substitution of K for Na in everted gut sac preparations results in 
an almost instantaneous cessation of bile salt transport (74, 75). However, 
+ 
when bile salts are incubated with Na under anerobic conditions, uptake 
into the intestinal wall occurs but concomitant concentration across the 
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serosa requires Na ions in addition to some energy-yielding process that 
is oxygen dependent. A sodium ion-activated ATPase is thought to mediate 
this process (75). Indeed, the cardiac glycoside ouabain, an ATPase in¬ 
hibitor, is known also to inhibit bile acid transport (78). These facts 
imply that uptake of bile acids is coupled to the sodium pump and is thus 
an example of a secondary active transport process. 
Conjugation of a bile acid is not necessary for its active trans¬ 
port. However, the nature of the conjugating group may affect the rate of 
transport. There is some indirect evidence that only one carrier system 
is involved in shuttling the different kinds of bile acid across the ileal 
wall. Holt (74) and Playoust and Isselbacher (75) have shown that the 
uptake of sodium taurocholate by the ileum may be competitively inhibited 
by the prior presence of other bile acids, suggesting that a single carrier 
is involved. Infact, the kinetics of active bile acid transport has been 
shown to follow the saturation kinetics of Michaelis-Menten (73, 75, 76). 
For a particular bile acid, the maximum velocity for its transport 
across the ileal wall increases rapidly from the proximal to the distal 
end (76), consistent with the rapid increase in receptor sites form the 
proximal to the distal end of the ileum. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Solutions and Reagents 
1. Buffers for dissociation of enterocytes: "Buffer I" had the following 
composition: 1.5 mM in KC1, 96 mM in NaCl, 27 mM in sodium citrate, 
8 mM in KHoP0, and 5.6 mM in NaoHP0.. The pH was 7.4. "Buffer II" 
2 4 2 4 
contained 2.7 mM KC1, 137 mM NaCl, 1.5 mM KHoP0., 8 mM Na HPO , 1.5 mM 
2 4 2 4 
Na2EDTA, and 0.5 mM in dithiothreitol. The pH was 7.4. 
2. Hanks buffer was purchased as such from Grand Island Biological Company, 
Grand Island, New York. 
3. Krebs-Ringers-Bicarbonate solution had a pH of 7.4. 
4. Cell culture medium consisted of 1.5 gm% BSA in Cbl-free NCTC-135. 
NCTC-135 was obtained from GIBCO, Grand Island, New York. 
5. Intrinsic Factor: The source of intrinsic factor was human gastic juice, 
obtained during gastric secretion studies after petagastrin stimulation. 
Only the first 30 minute post pentagastrin aspirates were used. In order 
to prevent the degradation of IF, the gastric juice was depepsinized by 
elevating the pH to 10 by the addition of 1 N NaOH. After 30 minutes, 
the pH was returned to 7 using HC1. 
We used human intrinsic factor because previous work has shown that the 
receptors on guinea pig ileal mucosa bind human IF. 

6, IF- CoCbl: Human gastric juice was reacted with an excess of CoCbl 
and the free ^CoCbl was removed using hemoglobin-coated charcoal (84). 
^ CoCbl, 10 yCi/0.667 ug/ml, was obtained from Radiochemical Center, 
Amersham, England. 
7. A 5 mM solution of non-labeled sodium taurocholate (NaTC) was prepared 
by dissolving 13.4 nm NaTC in 5 ml of NCTC/BSA medium. A 5 yM solution 
3 
of taurocholate, containing 1 yCi/ml of H-labeled taurocholate was 
3 
prepared by mixing the appropriate quantity of H-taurocholate with 
enough non-labeled taurocholate to make the final solution 5 yM in 
3 
taurocholate. Taurocholic acid- H(G) was obtained from New England 
Nuclear, Boston, Mass.; the activity was 1 yCi/0.15 mg/ml. 
2.2 Animals 
Adult guinea pigs of either sex weighing between 400 and 800 gm 
were used. The animals lived under constant artificial illumination and 
had unrestricted access to food and water. Animals were selected at random 
and starved overnight before use. 
2.3 Preparation of Villous and Crypt Cell Suspensions 
Under ether anesthesia, the small intestine of the animal was 
removed and divided into three equal segments. The proximal third (jejunal 
segment) and distal third (ileal segment) were used in these studies. The 
middle third was discarded. The mucosal surface of the intestinal segments 
were washed thoroughly with ice-cold saline to remove mucus and food residues. 
One end of each intestinal segment was clamped with a Spencer Wells artery 
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forceps and the lumen was filled with "Buffer I", previously equilibriated 
to 37°C and oxygenated. The open end of the intestinal segment was clamped 
and the entire loop of intestine placed in a 250 ml plastic Erlenmeyer 
flask containing 50 ml of "Buffer I". The flask was then incubated in a 
water bater bath at 37°C with continuous agitation. The contents of the 
flask were maintained under constant oxygenation with a mixture of 95% 0^ 
and 5% After incubating for 15 minutes in "Buffer I", the contents 
of the intestinal loop were discarded, the lumen was rinsed throughly with 
"Buffer II" and filled with this latter buffer in the manner described above 
for "Buffer I". The cells obtained at the end of this incubation were kept 
(this represented the "villous cell fraction"), and the series of incubations 
and washings were continued, as shown schematically in Fig. 2.1. 
Enzyme analyses of the cell fractions obtained at each of the above 
steps established the existence of a gradient of enzyme activity that was 
consistent with the release of predominantly villous cells at the end of 
the first Buffer II incubation and the release of predominantly crypt cells 
at the end of the last Buffer II incubation (see "Results"). 
The cells were centrifuged at 150 g for 5 minutes. A small aliquot 
was removed, washed in KRB, resuspended in water, homogenized, and used for 
enzyme assays. The remaining cells were rinsed twice with Hanks Buffer and 
finally suspended in NCTC/BSA. 
2.4 Enzyme Assays 
After appropriate dilution of the harvested cells, aliquots were 
taken and homogenized. The protein content of the cell homogenate was 
determined by the method of Lowry (85) using BSA as standard. Sucrase 

FIGURE 2.1 
Intestinal Segment (Jejunum or Ileum) 
T 
Step (1) Rinsed with ice-cold saline 
Step (2) Filled with Buffer I 
15 min. incubation at 37°C 
Contents of intestinal loop discarded 
>' 
Step (3) Filled with Buffer II 
15 min. incubation at 37°C 
Contents of loop kept ("VILLOUS CELL FRACTION") 
i 
Step (4) Filled with Buffer II 
15 min. incubation at 37°C 
Contents of loop discarded 
I 
Step (5) Filled with Buffer II 
5 min. incubation at 37°C 
Contents of loop discarded 
I 
Step (6) Filled with Buffer II 
20 min. incubation at 37°C 
Contents of loop kept ("CRYPT CELL FRACTION") 
Figure 2.1: Flow diagram for obtaining villous and 
crypt cell preparations. 
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activity was determined by the method of Dahlqvist (81); using the results 
of the protein assay, the sucrase activity was expressed as "enzyme units 
per minute incubation per mg. protein", where a unit of sucrase activity 
is defined as that quantity of enzyme which hydrolyzes 1.0 ymole of disac¬ 
charide (sucrose) per minute (81). 
Alkaline phosphatase activity was determined by the method of as 
modified by Weiser (82). The assay was carried out in 10 mM Tris-HCl buffer 
(pH 9.5) using disodium p-nitrophenyl phosphate as substrate. 
Acid phosphatase was assayed using disodium p-nitrophenyl phosphate 
as substrate in an 0.1 M acetate buffer (pH 5.2). Incubation time was 10 
minutes and enzyme activity was expressed as ymole p-nitrophenol per min. 
per mg. protein. 
Thymidine kinase was assayed according to the method of Chen et al 
14 . . 14 (83), based on the conversion of (2- C) thymidine to (2- C) thymidylate. 
Because the total final volume of the assay mixture was only 55yl, the 
assay was carried out in small conical plastic tubes which permitted good 
vortexing. At the end of the 8-minute incubation period, a 25 yl aliquot 
was transferred onto 23 mm discs of Whatman filter paper impreganted with 
DE 81. The latter were placed in a beaker containing 25 ml of a 1 mM 
solution of ammonium formate at room temperature. The ammonium formate 
14 
wash was necessary to remove unreacted (2- C) thymidine. The beaker was 
swirled for 15 minutes by means of a gyratory water bath and the ammonium 
formate was decanted off. After a further rinsing with 25 ml of ammonium 
formate and two water rinses, the disc was oven dried and counted in a 
toluene-based scintillation fluid. Thymidine kinase activity was expressed 
as counts per min. per min. incubation per mg. protein. 
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2.5 Cell Viability Studies 
To verify the viability of the cell preparations, 1.0 ml aliquots 
of crypt and villous cells in NCTC/BSA were incubated with 2 yCi each of 
14 
C-labeled leucine. Incubation was done in duplicate for six time points 
(5, 10, 15, 20, 30, and 45 minutes) and was terminated with 10 ml of ice- 
cold KRB containing a large excess (20 mil) of unlabeled leucine. The pro¬ 
ducts were centrifuged at 2,000 g, and the resulting pellets washed with 
KRB and taken up and homogenized in 4.0 ml of 20% Trichloroacetic acid 
(TCA) containing 20 mil unlabeled leucine. The homogenized cells were 
centrifuged at 27,000 g for 10 minutes and washed thoroughly by successively 
suspending and centrifuging in 10% TCA, 5% TCA, and 50:50 v/v methanol/ 
chloroform. The methanol/chloroform was evaporated in air and the pellet 
solubilized using a quaternary ammonium base in toluene (NCS, Amersham/ 
Searle). The solubilized pellet was transferred quantitatively with a 
toluene-based scintillation fluid into counting vials and the radioactivity 
determined against a toluene blank. The results were expressed as dis¬ 
integrations per minute (dpm) of leucine incorporated into 1 mg of cell 
protein. 
2.6 IF-Cbl Binding Studies 
Freshly prepared intestinal cells were washed twice with Hanks 
buffer and resuspended in NCTC/BSA medium. The volume of NCTC/BSA medium 
used to resuspend the cells depended on the yield of the latter. The 
"crypt" cell fraction was suspended in about 5 ml of medium. Because of 
the usually larger yield of "villous" cells, they were made up in about 
12 ml of medium in order to achieve cell concentrations comparable to the "crypt" 
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cell fraction. 3.75 ml of NCTC/BSA medium was pipeted into four of eight 
25 ml palstic Erlenmeyer flasks and equilibriated to 37°C in a gyratory 
water bath. 3.96 ml of medium was pipeted into each of the remaining four 
Erlenmeyer flasks (see table 2.1) . The flasks were continuously gassed 
with 95% C^, 5% CC^- Four of the flasks represented duplicate incubations 
of villous cells with free Cbl and with IF-Cbl; the other four represented 
similar incubations with "crypt" cells. 
1.0 ml aliquots of the appropriate cell suspension were then pipeted 
into the flasks. This was followed by the addition of the appropriate 
quantities (see table 2.1) of either free Cbl or IF-Cbl containing 2.0 ng 
of ”^Co. The flasks were incubated at 37°C for 30 minutes. At the end of 
this time the reaction was terminated by adding 10 ml of ice-cold KRB to 
each flask. The contents of each flask were transferred quantitatively to 
plastic tubes, which were then centrifuged at 2000 g. The resulting cell 
pellet was washed twice with 10 ml of KRB and the radioactivity determined. 
Uptake of free ^CoCbl or of IF-^^CoCbl was calculated as picogram ^CoCbl 
bound per mg. cell protein. The experimental protocol for the cobalamin 
binding experiment is summarized in Table 2.1. 
2.7 Bile Acid Uptake Studies 
Freshly prepared intestinal cells (jejunal and ileal) were washed 
twice with Hanks buffer and resuspended in NCTC medium containing 0.5% BSA. 
Because of its larger yield, the "villous" cell preparation was resuspended 
in a larger (about 12 ml) volume of NCTC medium compared to the "crypt" cell 
fraction which was suspended in about 5 ml of medium. 
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TABLE 2.1 
Sample 
No. 
NCTC 
medium 
(ml) 
Cells in 
NCTC medium 
(ml) 
IF-57CoCbl 
8.0 ng/ml 
(ml) 
Free CoCbl 
5.34 ng/ml 
(ml) 
** * 
"VILLOUS" 1 3.75 1.0 0.25 — 
CELL 2 3.75 1.0 0.25 - 
FRACTION 3 3,96 1.0 - 0.44 
4 3.96 1.0 - 0.44 
"CRYPT" 5 3.75 1.0 0.25 - 
CELL 6 3.75 1.0 0.25 - 
FRACTION 7 3.96 1.0 - 0.44 
8 3.96 1.0 - 0.44 
* 57 
These volumes contain 2.0 ng of Co; IF-Cbl preparations were always 
checked against a Co standard at the start of each experiment. 
* * 
These volumes are necessary to make the f inal volume 5.0 ml in each flask. 
Table 2.1: Experimental protocol for the binding of free 
^7CoCbl or IF-^CoCbl to "villous" and "crypt" 
cells. 
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3.90 ml of NCTC/BSA medium was pipeted into each of six plastic 
25 ml Erlenmeyer flasks and incubated at 37°C. These six flasks represented 
triplicate incubations of "villous" and "crypt" cells at a total taurocho- 
late concentration of 1 yM (see table 2.2) . 2.90 ml of NCTC/BSA medium and 
1.0 ml of 5 mM unlabeled taurocholate were pipeted into each of four plastic 
Erlenmeyer flasks which were similarly equilibriated to 37°C. These repre¬ 
sented duplicate incubations of "villous" and "crypt" cells at a total 
taurocholate concentration of 1 mM. (Since the total taurocholate concen¬ 
tration in the latter set of flasks was 1000 fold greater than that in the 
first set, it was possible to correct for the uptake of radioactive tauro¬ 
cholate that was due to "nonspecific" binding; see "Results"), 
1.0 ml aliquots of the appropriate cell preparation were then 
pipeted into each flask. This was followed by the the addition of 0.1 ml 
of the labeled taurocholate solution to each flask. Labeled taurocholate 
solution was added at half-minute intervals so that each flask was incubated 
for exactly 5 minutes at 37°C. 
The incubations were stopped by the addition of 10 ml of ice-cold 
KRB, with quantitative transfer of the contents of the flasks to plastic 
tubes which were then centrifuged at 2000 g. The resulting pellet was 
washed with 15 ml of KRB and solubilized using 1 ml of NCS. The solubilized 
pellet was taken up quantitatively in a toluene-based scintillation fluid 
and its radioactivity determined. Bile acid uptake was calculated as the 
3 
amount of H uptake (in cpm) in 5 minutes per mg. protein. Table 2.2 
summarizes the protocol for the bile acid uptake studies. 
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TABLE 2.2 
Sample Medium 5 mM NaTC Cells 
3 
H-TC 
No. (ml) (ml) (ml) (ml) 
"VILLOUS” o 1 3.9 1.0 
* 
0.1 
CELL H S 
FRACTION P- 
o 
2 3.9 - 1.0 0.1 
t—I 
3 3.9 - 1.0 0.1 
u 
H 
i 
4 2.9 1.0 1.0 
rH
 
O
 
o 
rH 
5 2.9 1.0 1.0 0.1 
"CRYPT" u 6 3.9 1.0 0.1 
CELL 
H 
2 
FRACTION 
3- 
c 
7 3.9 - 1.0 
1—1
 
O
 
rH 
_8 3.9 - 1.0 0.1 
u 
— 
H 
9 2.9 1.0 1.0 0.1 
O 
T-1 10 2.9 1.0 1.0 
0.1 
* 
contains 1.0 yCi of 3H-TC 
Table 2.2: Experimental protocol for the uptake of 
3 
H-Taurocholate by guinea pig ileal cells. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
3.1 Enzyme Assays 
Tables 3.1 and 3.2 show the results of the enzyme assays on the 
villous and crypt cell fractions respectively in five different experi¬ 
ments. Most of the enzyme activities shown represent the mean of two or 
three determinations depending on the number of serial dilutions used. 
The only exceptions to this are the sucrase data in Fig. 3.2; these 
represent single determinations for each experiment because only the 
smallest dilutions showed any measurable sucrase activity. 
In Fig. 3.1, the mean enzyme activities for the five experiments 
have been calculated from Tables 3.1 and 3.2 and the results are shown 
graphically for easy comparison. The highest specific activity for each 
enzyme has been arbitrarily set at 100% to obtain relative activity. It 
can be seen that most of the sucrase and alkaline phosphatase was located 
in the villous cell fraction, with the crypt cell fraction showing only 
9-10% of the activity of the villous fraction. Acid phosphatase, on the 
other hand, was about equally distributed between the two cell fractions 
whilst thymidine kinase predominated in the crypt cell fraction. 
An alternative way of examining the data that allows easy comparison 
with previous work done in this field is shown in Table 3.3. The ratios of 
enzymatic activity in crypt cells to villous cells were calculated from the 
mean enzymatic activities of Tables 3.1 and 3.2. Comparison of Table 3.3 
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TABLE 3.1 
Expt. No. 
Sucrase 
(enzyme 
units/min/ 
mg protein) 
Alkaline 
Phos. (ymoles 
pnp/min/ 
mg protein) 
Acid Phos. 
(ymoles 
pnp/min/ 
mg protein) 
Thymidine 
Kinase 
(cpm/min/ 
mg protein) 
1 0.092 0.10 0.09 351 
2 0.065 0.59 0.085 496 
3 0.069 0.65 0.087 663 
4 0.063 0.123 0.069 250 
5 0.076 0.232 0.119 245 
Mean + S.D 0.0730 0.3390 0.090 401 
+ 0.0117 + 0.2622 + 0.0181 + 178 
Table 3.1: Results of enzyme assays on the first 15 minute ("villous") 
fraction of guinea pig ileal cells. The method of preparation 
of cells is described in Sec. 2.3; the various enzyme assays 
are described in Sec. 2.4. 
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TABLE 3.2 
Exp. No. 
Sucrase 
(enzyme 
units/min/ 
mg protein) 
Alkaline 
Phosph (pmoles 
pnp/min/ 
mg protein) 
Acid Phosph. 
(ymoles 
pnp/min/ 
mg protein) 
Thymidine 
Kinase 
(cpm/min/ 
mg protein) 
1 0.0195 0.02 0.07 4096 
2 0.006 0.046 0.079 4797 
3 0.003 0.020 0.073 6124 
4 0.0075 0.025 0.082 8499 
5 < 0.001 0.038 0.099 4462 
Mean + S.D. 0.0074 0.0298 0.0806 5596 
+ 0.0072 + 0.0117 + 0.0113 + 1794 
Table 3.2: Results of enzyme assays on the last 20 minute ("crypt") 
fraction of guinea pig ileal cells. The method of preparation 
of cells is described in Sec. 2.3. The various enzyme assays 
are described in Sec. 2.4. 
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FIGURE 3.1 
□ VILLOUS 
.« CRYPT 
100$ 
10$ 
♦ • « 
• • e 
0 e o 
100$ 
90$ 
100% 
Sucrase Alkaline Acid 
Phosphatase Phosphatase 
Thymidine 
Kinase 
Figure 3.1: Distribution of enzymes in the two cell fractions of 
the guinea pig ileum. The highest specific activity for each enzyme 
was arbitrarily set at 100% to obtain relative activity. Each bar 
represents the mean of five different cell preparations. 

-40- 
with Table 1.1 shows excellent agreement, indicating good separation of 
crypt from villous cells by the method we used. 
3.2 Cell Viability Studies 
Fig. 3.2 shows a plot of the uptake of radioactive leucine by 
ileal villous and crypt cells. The ordinate represents the amount of 
14 
C-leucine incorporated up to the time shown on the absicca. Excluding 
the outlier at the 45 minute point for the crypt cells, the rate of incor¬ 
poration is seen to be linear initially and to gradually level off with 
time, suggesting that both crypt and villous cell preparations were viable, 
at least with respect to protein synthesis. 
3.3 Cobalamin Binding Studies 
The first set of experiments (Nos. 1-5 in Table 3.4) compared the 
uptake of free and IF-bound ^CoCbl in ileal villous cells. IF-mediated 
uptake was found to be 40-fold greater than uptake of free Cbl by the 
same cells under identical conditions. 
In the second set of experiments (Nos. 6-10, Table 3.5), uptake of 
free and IF-bound ~^CoCbl by ileal crypt cells was measured. IF-mediated 
uptake was absent with ileal crypt cells. In fact, the uptake of IF-~^CoCbl 
by these cells was not signicantly different from their non-specific bind¬ 
ing to free Cbl. 
Having established the lack of uptake of IF-Cbl by ileal crypt 
cells, it was of interest to compare jejunal and ileal crypt cells with 
respect to their capabilities for IF-Cbl uptake. To do this, crypt cells 
from the proximal third (jejunum) and the distal third (ileum) were harvested 
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TABLE 3.3 
Ratio of enzymatic 
activity in crypt cells 
to villous cells 
Literature 
Values Reference 
Sucrase 0.10 0.11 (29) 
Alkaline Phosphatase 0.09 0.49 (34) 
Acid Phosphatase 0.90 0.83 (31) 
Thymidine Kinase 14.0 50.00 (26) 
Table 3.3: Crypt/villous ratios of enzymatic activity calculated from 
the mean enzymatic activities of Tables 3.1 and 3.3. Com¬ 
parison is made with literature values. Numbers in parentheses 
refer to the sources of the literature values. Qualitative 
agreement the measured ratios and the literature values is 
excellent. 
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FIGURE 3.2a 
Incorporation of C-labeled leucine into 
protein by ileal villous cells. The graph 
is linear initially but tends to level off 
with time, thus verifying cell viability. 
Figure 3.2a: 
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FIGURE 3.2b 
10 20 30 40 50 
Time (minutes) 
14 
Figure 3.2b: Incorporation of C-labeled leucine into 
protein by ileal crypt cells. The graph 
is linear initially but tends to level off 
with time, thus verifying cell viability. 
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TABLE 3.4 
Expt. No. 
Ileal villous cell uptake of 
Free 57CoCbl IF-57CoCbl 
(pg/mg protein) (pg/mg protein) 
Ratio of uptake of 
IF-57CoCbl to 
Free57CoCbl 
1 4.0 180 45.0 
2 2.0 110 55.0 
3 6.0 193 32.2 
4 7.0 281 40.0 
5 4.0 140 35.0 
Mean + S.D. 4.60 + 1.9 181 + 65 41.4 + 9.0 
Table 3.4: Results of the uptake of Free and IF-bound CoCbl by 
ileal villous cells. 
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TABLE 3.5 
Expt. No. 
Ileal crypt cell uptake of 
Free 57CoCbl IF-57CoCbl 
(pg/mg protein) (pg/mg protein) 
Ratio of uptake of 
IF-57CoCbl to 
Free 57CoCbl 
6 Not done 4.25 - 
7 4.0 6.0 1.5 
8 3.0 6.0 2.0 
9 3.4 5.6 1.6 
10 2.2 1.8 0.8 
Mean + S.D. 3.2 + 0.8 4.73 + 1.8 1.5 + 0.5 
Table 3.5: Results of the uptake of free and IF-bound 
ileal crypt cells. 
TABLE 3.6 
57CoCbl by 
IF- CoCbl uptake Free CoCbl uptake 
(pg/mg protein) (pg/mg protein) 
Jejunal Crypts 0.68 2.1 
Ileal Crypts 3.0 3.2 
Table 3.6: Comparison of the uptake of free and IF-bound “*7CoCbl by 
jejunal and ileal crypt cells. 
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and used for binding experiments in the manner already described. The 
results of this experiment are shown in Table 3.6. Again, IF-^^CoCbl up¬ 
take was absent or insignificant with either ileal crypt or jejunal crypt 
cells. IF-mediated uptake of ~^CoCbl by ileal crypt cells exceeded slightly 
the corresponding uptake by jejunal crypt cells. Because of the low levels 
of uptake in both ileal crypt and jejunal crypt cells, this may just repre¬ 
sent experimental error. More likely, the difference was the result of 
the inevitable slight contamination of crypt cells with villous cells. 
Contamination of ileal crypt cells with ileal villous cells would be 
expected to lead to a higher than expected level of uptake by the former 
since ileal villous cells bound IF-Cbl avidly. On the other hand, con¬ 
tamination of jejunal crypt cells with jejunal villous cells would not be 
expected to result in any higher levels of Cbl uptake since jejunal villous 
cells themselves lack the capacity for such. Fig. 3.3 shows graphically 
the results of this section. 
3.4 Bile Acid Uptake Studies 
3 
Tables 3.7 and 3.8 summarize the data for the uptake of H-Tauro- 
cholate by jejunal and ileal villous and crypt cells. It can be seen that 
ileal villous cells showed a level of uptake 35-40 fold greater than uptake 
by ileal crypt or jejunal crypt or villous cells incubated under identical 
conditions. This is shown graphically in Fig. 3.4. It must be remembered 
that in these data, the term "uptake" refers to the net uptake after correc¬ 
tion has been made for the so-called "non-specific binding". The latter 
refers to the binding of bile acids to sites other than the surface recep¬ 
tors specific for the transport of bile acids. To correct for this, 
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m VILLOUS CELL UPTAKE OF IF-CBL VILLOUS CELL UPTAKE OF FREE CBL 
□ CRYPT CELLS UPTAKE OF IF-CBL ED CRYPT CELL UPTAKE OF FREE CBL 
Figure 3.3: Uptake of Free and IF-bound CoCbl by guinea 
pig jejunal and ileal crypt and villous cells. 
Drawn from Tables 3.4 - 3.6. 

-48- 
|7^Tj JEJUNAL VILLOUS CELL 
UPTAKE OF 3H-TC 
[ | ILEAL VILLOUS CELL 
UPTAKE OF 3H-TC 
F77] JEJUNAL CRYPT CELL 
UPTAKE OF H-TC 
g ILEAL CRYPT CELL 
3 
Figure 3.4: Uptake of H-Taurocholate by guinea pig jejunal 
and ileal crypt and villous cells. Drawn from 
Tables 3.7 and 3.8. 
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TABLE 3.7 
Uptake 
3 
of H-Taurocholate by villous cells of 
Expt. No. Jejunum Ileum 
1 87 3463 
2 112 3521 
3 72 2485 
Mean + S.D. 90 + 20 3156 + 582 
Table 3.7: 
3 
Results of the uptake of H-Taurocholate by jejunal and 
ileal villous cells. 
TABLE 3.8 
Uptake 
3 
of H-Taurocholate by crypt cells of 
Expt. No. J e junum Ileum 
4 93 115 
5 61 99 
6 74 44 
7 
* 
110 90 
Mean + S.D. 84 + 21 87 + 30 
Table 3.8: Results of the uptake of H-Taurocholate by jejunal and 
ileal crypt cells. 
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incubations were done in solutions containing 1 ]iM of total taurocholate 
(labeled and unlabeled) as well as in 1 mM solutions. Since the total 
amount of labeled taurocholate was constant in each flask, the ratio of 
labeled to unlabeled taurocholate was 1000-fold greater in the 1 ]lM solu¬ 
tions than in the 1 mM solutions. Subtraction of the ’’uptake" of the 1 mM 
incubations from that in the 1 yM incubations gave the desired corrected 
uptake that is shown in Tables 3.7 and 3.8. 
It may be concluded from the results of this section that only 
ileal villous cells prossess the mechanism for the active uptake of bile 
salts. 
3.5 Conclusion 
The process by which epithelial cells of the crypts of Lieberkuhn 
divide, differentiate, migrate to the tip of the villus, and eventually 
desquamate has intrigued cell biologists because of its suitability for 
the biochemical study of cell maturation in general. It has also been of 
keen interest to investigators of intestinal absorption and secretion in¬ 
asmuch as the enzymatic potential of crypt cells may be of importance in 
the overall absorptive and digestive capacity in those disease states in 
which either the intestinal surface is continually denuded, or the normal 
crypt to villous maturation is impaired. 
Several different approaches to studing this phenomenon have been 
reported, including autoradiographic (1), biochemical (12, 13, 14, 89) and 
histochemical (90). In earlier studies, the histochemical approach was 
favored bacause it was capable of providing information on the distribution 
of enzymatic activity as a function of the location of the cell along the 
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crypt-villous axis. With the advent of biochemical methods of cell frac¬ 
tionation, it has been possible to study not only crypt-villous differences 
but also differences in subpopulations of villous cells according to their 
age and/or location on the villous axis (12, 89, 25). 
Our studies have established the existence of biochemical and 
functional differences between the undifferentiated crypt cells and the 
well differentiated villous cells. Whereas the villous cells were rich 
in alkaline phosphatase and sucrase, the crypt cell fraction contained 
nearly all of the thymidine kinase, consistent with the propensity of the 
crypt cell for cell division. It may be inferred from this distribution 
of enzymatic activity that as the crypt cell matures, certain gene regu¬ 
lators are activated whilst other genes are repressed; this results in 
the cessation of the synthesis of the enzymes necessary for DNA synthesis 
and the initiation of the production of brush border enzymes. By a similar 
mechanism, maturation of the crypt cell is accompanied by the synthesis of 
cell surface receptor proteins that are necessary for the binding and 
transport of dietary and other nutrients such as bile salts and cobalamin. 
In previous work, the absorption of glucose, amino acids and 
electrolytes have been shown to be a function of the villous cell (91), as 
is the absorption of triglycerides (92). On the other hand, the secretion 
of electrolytes is thought to be a function of the crypt cell. On the 
basis of this rather limited information, the generalization has been made 
that the villous cell serves a primarily absorptive function whereas the 
crypt cell, in addition to its role in replenishing the villous cell popu¬ 
lation, has a secretory function. Our study has shown that two very 
different molecules - conjugated bile salts and cobalamin - both of which 
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share a common feature in the sense that their active transport occurs 
only in the ileum, are taken up by villous cells and not by crypt cells. 
This further supports the concept that the absorptive functions of the 
intestine are performed by the villous cells. 
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